PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS

Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more...

Full description

Saved in:
Bibliographic Details
Main Authors FLORJANCIC, ALAN S, GOSWAMI, RAJEEV, TONG, YUNSONG, SOUERS, ANDREW J, PENNING, THOMAS
Format Patent
LanguageEnglish
French
Published 02.10.2014
Subjects
Online AccessGet full text

Cover

Loading…